Javascript must be enabled to continue!
e0147 Mechanism of different activators of PPARαregulating plasminogen activator inhibitor-1 expression
View through CrossRef
Objective
To observe the effects of fenofibrate and linoleic acid which was the different activators of PPARα on the expression of PAI-1 and PPARα in HepG2 cells. To investigate the relationship and mechanisms between the promoter and expression of PAI-1 that how the fenofibrate and linoleic acid to act on PAI-1. And to observe if PPARα involved in this procession.
Methods
HepG2 cells were exposed to fenofibrate and linoleic acid in varying concentrations, RT-PCR was used to determine the mRNA expression of PAI-1 and PPARα. Several luciferase reporter gene recombinant plasmid containing different length sequences of human PAI-1 gene promoter from −804 to +17bp were constructed and transiently transfected into HepG2 cells. At the same time, co-transfected with PPARα-pSG5 expression plasmid, then different stimulating factors were added to induce the transfected cells. Transcriptional activity of PAI-1 was demonstrated by the measure of luciferase activity.
Results
1. Fenofibrate could remarkably decreased PAI-1 mRNA expression in HepG2 cells (p<0.05 or p<0.01), but linoleic acid could significant increased PAI-1 mRNA level (p<0.05 or p<0.01), and they were all in a concentration-dependent manner. 2. Fenofibrate and linoleic acid could raise the mRNA level of PPARα (p<0.05 or p<0.01), which were also in a concentration-dependent way. 3. The PAI-1 transcriptional activity were significantly suppressed by fenofibrate (p<0.05), but induced by linoleic acid (p<0.01) in HepG2 cells transfected with PAI-pGL3 total length promoter constructs. 4. When co-transfected with PPARα-pSG5, fenofibrate could suppress the level of PAI-1 transcription further more (p<0.05), while increased y linoleic acid (p<0.01). 5. The PAI-1 transcriptional activity were very inconsistent when transfected with the plasmid containing different length sequences of human PAI-1 gene promoter from −804 to +17 bp.
Conclusions
Fenofibrate and linoleic acid could increase the mRNA level of PPARα, and they regulate the synthesis of PAI-1 from transcriptional level, which was concerned with the activated of PPARα by Fenofibrate and linoleic acid. The sequences that could regulate the expression of PAI-1 gene induced by fenofibrate might exist in the areas from −804 to −636 and −636 to −449 of PAI-1 promoter and existed in the areas rom −804 to −636 and −449 to −276 induced by linoleic acid. The effects on expression of PAI-1 were very inconsistently, so there might be other mechanisms involved.
Title: e0147 Mechanism of different activators of PPARαregulating plasminogen activator inhibitor-1 expression
Description:
Objective
To observe the effects of fenofibrate and linoleic acid which was the different activators of PPARα on the expression of PAI-1 and PPARα in HepG2 cells.
To investigate the relationship and mechanisms between the promoter and expression of PAI-1 that how the fenofibrate and linoleic acid to act on PAI-1.
And to observe if PPARα involved in this procession.
Methods
HepG2 cells were exposed to fenofibrate and linoleic acid in varying concentrations, RT-PCR was used to determine the mRNA expression of PAI-1 and PPARα.
Several luciferase reporter gene recombinant plasmid containing different length sequences of human PAI-1 gene promoter from −804 to +17bp were constructed and transiently transfected into HepG2 cells.
At the same time, co-transfected with PPARα-pSG5 expression plasmid, then different stimulating factors were added to induce the transfected cells.
Transcriptional activity of PAI-1 was demonstrated by the measure of luciferase activity.
Results
1.
Fenofibrate could remarkably decreased PAI-1 mRNA expression in HepG2 cells (p<0.
05 or p<0.
01), but linoleic acid could significant increased PAI-1 mRNA level (p<0.
05 or p<0.
01), and they were all in a concentration-dependent manner.
2.
Fenofibrate and linoleic acid could raise the mRNA level of PPARα (p<0.
05 or p<0.
01), which were also in a concentration-dependent way.
3.
The PAI-1 transcriptional activity were significantly suppressed by fenofibrate (p<0.
05), but induced by linoleic acid (p<0.
01) in HepG2 cells transfected with PAI-pGL3 total length promoter constructs.
4.
When co-transfected with PPARα-pSG5, fenofibrate could suppress the level of PAI-1 transcription further more (p<0.
05), while increased y linoleic acid (p<0.
01).
5.
The PAI-1 transcriptional activity were very inconsistent when transfected with the plasmid containing different length sequences of human PAI-1 gene promoter from −804 to +17 bp.
Conclusions
Fenofibrate and linoleic acid could increase the mRNA level of PPARα, and they regulate the synthesis of PAI-1 from transcriptional level, which was concerned with the activated of PPARα by Fenofibrate and linoleic acid.
The sequences that could regulate the expression of PAI-1 gene induced by fenofibrate might exist in the areas from −804 to −636 and −636 to −449 of PAI-1 promoter and existed in the areas rom −804 to −636 and −449 to −276 induced by linoleic acid.
The effects on expression of PAI-1 were very inconsistently, so there might be other mechanisms involved.
Related Results
Kinetics Of Plasminogen Activation By Tissue Plasminogen Activator. Role Of Fibrin
Kinetics Of Plasminogen Activation By Tissue Plasminogen Activator. Role Of Fibrin
The activation of human plasminogen (P) by two-chain tissue plasminogen activator (A) was studied in the presence of fibrin films (F) of increasing size and surface density. Initia...
Physiology of Plasminogen: With Special Reference to Activation and Degradation
Physiology of Plasminogen: With Special Reference to Activation and Degradation
Plasminogen is said to be synthesized in many organs, but the major source of its production is considered to be the liver. The production of plasminogen is observed in fetal life,...
Binding of human plasminogen to Borrelia burgdorferi
Binding of human plasminogen to Borrelia burgdorferi
We studied the binding of plasminogen to Borrelia burgdorferi, a spirochete which causes Lyme disease and produces no endogenous proteases which digest extracellular matrix protein...
On The Fibrinolytic Properties Of Single-Chain And Two- Chain Human Tissue Plasminogen Activator
On The Fibrinolytic Properties Of Single-Chain And Two- Chain Human Tissue Plasminogen Activator
Tissue plasminogen activator from pig hearts may be isolated as a single-chain or as a two-chain molecule (Wallén et al., 1980). The present report deals with the two molecular for...
The Plasminogen (Fibrinolytic) System
The Plasminogen (Fibrinolytic) System
Introduction
The plasminogen (fibrinolytic) system (Fig. 1) comprises an inactive proenzyme, plasminogen, that can be converted to the active enzyme, plasmin. Pla...
Hypercoagulability Markers in Patients with Peripheral Arterial Disease: Association to Ankle-brachial Index
Hypercoagulability Markers in Patients with Peripheral Arterial Disease: Association to Ankle-brachial Index
Peripheral arterial disease is diagnosed by measuring the ankle-brachial index. Values lower than 0.90 define the disease being usually related to its severity. Patients with perip...
Comparative metabolism of plasminogen glycoforms I and II in the alloxan-diabetic rabbit
Comparative metabolism of plasminogen glycoforms I and II in the alloxan-diabetic rabbit
The metabolism of plasminogen glycoforms I and II was measured in alloxan-induced diabetic and in age-matched control rabbits. Radiolabeled plasminogen I and II were degraded signi...

